Allstate (NYSE:ALL) Given New $216.00 Price Target at UBS Group

Allstate (NYSE:ALL) had its target price boosted by UBS Group from $215.00 to $216.00 in a research report sent to investors on Tuesday morning, Benzinga reports. The firm currently has a buy rating on the insurance provider’s stock.

Several other research firms have also weighed in on ALL. Keefe, Bruyette & Woods increased their price target on Allstate from $199.00 to $208.00 and gave the company an “outperform” rating in a report on Monday, August 12th. JPMorgan Chase & Co. increased their price target on Allstate from $205.00 to $207.00 and gave the company an “overweight” rating in a report on Thursday, October 10th. Wells Fargo & Company reduced their target price on Allstate from $177.00 to $175.00 and set an “equal weight” rating on the stock in a research note on Friday, August 16th. Morgan Stanley reduced their target price on Allstate from $205.00 to $200.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 10th. Finally, Jefferies Financial Group increased their target price on Allstate from $217.00 to $231.00 and gave the stock a “buy” rating in a research note on Wednesday, October 9th. One research analyst has rated the stock with a sell rating, two have given a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $202.59.

Allstate Stock Down 0.0 %

NYSE ALL opened at $195.44 on Tuesday. The stock has a 50 day moving average price of $186.66 and a 200-day moving average price of $173.80. Allstate has a one year low of $121.70 and a one year high of $198.79. The company has a market capitalization of $51.58 billion, a P/E ratio of 43.14, a P/E/G ratio of 1.74 and a beta of 0.48. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.36 and a current ratio of 0.36.

Allstate (NYSE:ALL) last released its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $1.61 earnings per share for the quarter, beating the consensus estimate of $0.33 by $1.28. Allstate had a return on equity of 24.05% and a net margin of 5.03%. The company had revenue of $15.71 billion for the quarter, compared to analyst estimates of $14.04 billion. During the same quarter in the prior year, the firm posted ($4.42) EPS. Allstate’s quarterly revenue was up 12.4% compared to the same quarter last year. As a group, equities analysts predict that Allstate will post 15.19 EPS for the current fiscal year.

Insider Activity

In other news, EVP Elizabeth Brady sold 49,481 shares of the firm’s stock in a transaction on Friday, August 16th. The stock was sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the transaction, the executive vice president now owns 19,163 shares in the company, valued at approximately $3,431,901.67. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. In related news, EVP Robert Toohey sold 16,682 shares of the firm’s stock in a transaction dated Monday, August 19th. The stock was sold at an average price of $180.17, for a total transaction of $3,005,595.94. Following the sale, the executive vice president now owns 4,873 shares of the company’s stock, valued at $877,968.41. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Elizabeth Brady sold 49,481 shares of the firm’s stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $179.09, for a total value of $8,861,552.29. Following the sale, the executive vice president now directly owns 19,163 shares in the company, valued at approximately $3,431,901.67. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 192,530 shares of company stock worth $34,967,665. Company insiders own 1.80% of the company’s stock.

Institutional Investors Weigh In On Allstate

A number of institutional investors have recently added to or reduced their stakes in ALL. BDF Gestion acquired a new stake in Allstate in the second quarter worth about $3,051,000. BNP Paribas Financial Markets boosted its holdings in Allstate by 55.8% in the first quarter. BNP Paribas Financial Markets now owns 218,629 shares of the insurance provider’s stock worth $37,825,000 after acquiring an additional 78,316 shares in the last quarter. OFI Invest Asset Management acquired a new stake in Allstate in the second quarter worth about $476,000. Envestnet Portfolio Solutions Inc. boosted its holdings in Allstate by 12.5% in the first quarter. Envestnet Portfolio Solutions Inc. now owns 50,383 shares of the insurance provider’s stock worth $8,717,000 after acquiring an additional 5,586 shares in the last quarter. Finally, SG Americas Securities LLC boosted its holdings in Allstate by 251.8% in the first quarter. SG Americas Securities LLC now owns 53,090 shares of the insurance provider’s stock worth $9,185,000 after acquiring an additional 38,001 shares in the last quarter. Institutional investors own 76.47% of the company’s stock.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.